HUTCHMED (China) (HCM) Liabilities and Shareholders Equity (2016 - 2025)

HUTCHMED (China) (HCM) has disclosed Liabilities and Shareholders Equity for 10 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 37.58% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 billion, a 7.68% increase, with the full-year FY2025 number at $1.8 billion, up 37.58% from a year prior.
  • Liabilities and Shareholders Equity was $1.8 billion for Q4 2025 at HUTCHMED (China), up from $1.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q4 2025 to a low of $1.0 billion in Q4 2022.
  • A 5-year average of $1.3 billion and a median of $1.3 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 89.56% in 2021, then fell 25.0% in 2022.
  • HUTCHMED (China)'s Liabilities and Shareholders Equity stood at $1.4 billion in 2021, then dropped by 25.0% to $1.0 billion in 2022, then increased by 24.32% to $1.3 billion in 2023, then decreased by 0.44% to $1.3 billion in 2024, then skyrocketed by 37.58% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for HCM's Liabilities and Shareholders Equity are $1.8 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.3 billion (Q4 2023).